Collins Helen Louise (CIK 0001701247)

Latest company ownership

Role: CHIEF MEDICAL OFFICER
Shares held
816
Last filed at
Oct 22, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2024Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 18, 2024 Oct 22, 2024 Enliven Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 13.8 -816 -100.00% $24.5K
Apr 11, 2024 Apr 15, 2024 Enliven Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 7.5 -20,000 -100.00% $501.5K